- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
14
Stocks where the price continues to rise after more than a year of consistent gains.
14 companies
GemPharmatech
Market Cap: CN¥10.7b
A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.
688046
CN¥27.36
7D
21.5%
1Y
73.5%
Hansa Biopharma
Market Cap: SEK 4.0b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 39.42
7D
20.8%
1Y
44.4%
Intravenous Infusions
Market Cap: GH₵181.1m
A pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.
IIL
GH₵0.66
7D
43.5%
1Y
1,220.0%
PharmaCielo
Market Cap: CA$16.7m
Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.
PCLO
CA$0.075
7D
25.0%
1Y
50.0%
Delex Healthcare Group
Market Cap: US$5.1m
Engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.
DELX
US$0.0085
7D
57.4%
1Y
5.6%
BPH Global
Market Cap: AU$4.7m
Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.
BP8
AU$0.002
7D
33.3%
1Y
0%
Vaccinex
Market Cap: US$3.2m
A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.
VCNX
US$1.18
7D
35.6%
1Y
42.2%
International Stem Cell
Market Cap: US$2.5m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.31
7D
58.0%
1Y
59.4%
Innovation Pharmaceuticals
Market Cap: US$1.4m
A clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective.
IPIX
US$0.0027
7D
35.0%
1Y
800.0%
American Green
Market Cap: US$1.3m
Operates as a technology company in the medical cannabis industry in the United States.
ERBB
US$0.0003
7D
50.0%
1Y
0%
PAO Group
Market Cap: US$382.0k
Focuses on alternative patient care treatments.
PAOG
US$0.0002
7D
100.0%
1Y
19,900.0%
Myrexis
Market Cap: US$241.4k
Focuses on identifying, evaluating, and making financial investments in life sciences assets.
MYRX
US$0.007
7D
775.0%
1Y
3,400.0%
Cannonau
Market Cap: US$72.5k
Engages in the provision of cannabidiol based products.
CNNC
US$0.0003
7D
50.0%
1Y
200.0%
eFFECTOR Therapeutics
Market Cap: US$3.8k
A biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer.
EFTR
US$0.0008
7D
60.0%
1Y
33.3%